Colgate-Palmolive (NYSE:CL) Shares Acquired by Hancock Whitney Corp

Hancock Whitney Corp increased its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 28.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,584 shares of the company's stock after acquiring an additional 3,466 shares during the quarter. Hancock Whitney Corp's holdings in Colgate-Palmolive were worth $1,417,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. increased its stake in Colgate-Palmolive by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 81,303,059 shares of the company's stock valued at $7,391,261,000 after purchasing an additional 588,230 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Colgate-Palmolive by 1.6% during the 4th quarter. Geode Capital Management LLC now owns 20,518,014 shares of the company's stock valued at $1,868,723,000 after acquiring an additional 324,683 shares during the last quarter. Norges Bank purchased a new stake in shares of Colgate-Palmolive during the 4th quarter valued at about $912,375,000. Amundi boosted its holdings in shares of Colgate-Palmolive by 12.8% during the 4th quarter. Amundi now owns 9,200,144 shares of the company's stock valued at $806,015,000 after acquiring an additional 1,040,604 shares during the last quarter. Finally, Barclays PLC boosted its holdings in shares of Colgate-Palmolive by 38.7% during the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company's stock valued at $793,542,000 after acquiring an additional 2,132,747 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

CL has been the topic of a number of recent analyst reports. Raymond James reaffirmed an "outperform" rating and set a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Piper Sandler dropped their price objective on shares of Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a report on Monday, March 31st. Morgan Stanley dropped their price objective on shares of Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating on the stock in a report on Monday, February 3rd. Citigroup lifted their price target on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the company a "buy" rating in a report on Monday. Finally, UBS Group boosted their price target on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the stock a "buy" rating in a research note on Thursday, April 17th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $102.39.

Colgate-Palmolive Stock Down 1.0 %

CL stock traded down $0.93 during trading on Thursday, hitting $91.27. 1,183,774 shares of the company's stock traded hands, compared to its average volume of 4,654,696. The firm has a market capitalization of $73.96 billion, a P/E ratio of 25.89, a PEG ratio of 4.20 and a beta of 0.40. The business has a fifty day simple moving average of $92.28 and a two-hundred day simple moving average of $92.06. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a 1 year low of $85.32 and a 1 year high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.86 by $0.05. The company had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.92 billion. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. Colgate-Palmolive's revenue was down 3.0% compared to the same quarter last year. During the same period last year, the company posted $0.86 earnings per share. Sell-side analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Thursday, April 17th will be paid a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.28%. This is an increase from Colgate-Palmolive's previous quarterly dividend of $0.50. The ex-dividend date of this dividend is Thursday, April 17th. Colgate-Palmolive's dividend payout ratio (DPR) is 58.76%.

Colgate-Palmolive announced that its Board of Directors has authorized a stock buyback plan on Thursday, March 20th that permits the company to repurchase $5.00 billion in shares. This repurchase authorization permits the company to repurchase up to 6.8% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's leadership believes its shares are undervalued.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.